The Impact of State Dementia Training Requirements for Nursing Homes on Antipsychotic Medication Use

被引:2
|
作者
Shier, Victoria [1 ,5 ]
Bae-Shaaw, Yuna H. [2 ]
Sood, Neeraj [1 ]
Lekovitch, Cara [3 ]
Chew, Felicia [4 ]
Leland, Natalie E. [3 ]
机构
[1] Univ Southern Calif, Sol Price Sch Publ Policy, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90007 USA
[2] Univ Calif Los Angeles, USC Mann Sch Pharm & Pharmaceut Sci, Titus Family Dept Clin Pharm, Los Angeles, CA USA
[3] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, Pittsburgh, PA USA
[4] Thomas Jefferson Univ, Dept Occupat Therapy, Pittsburgh, PA USA
[5] 635 Downey Way, Los Angeles, CA 90089 USA
关键词
Regulations; staff; antipsychotic medications; LONG-TERM-CARE; PSYCHOLOGICAL SYMPTOMS; RISK; RESIDENTS; BURDEN; HYPERLIPIDEMIA; ASSOCIATION; RISPERIDONE; OLANZAPINE; CLOZAPINE;
D O I
10.1016/j.jamda.2023.10.017
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: Nursing home (NH) staff often report not having adequate dementia-specific knowledge to effectively care for these residents. Between 2011 and 2019, 9 states in the United States implemented dementia training requirements for NH staff. This study evaluated whether the state-mandated dementia training for NH staff was associated with improving resident outcomes. Design: Compared trends in antipsychotic medication before and after implementation of state training requirements to trends in states without requirements. Setting and Participants: NHs. Methods: Data from Care Compare for NHs and LTCFocus were linked to state policy data. We excluded 14 states that had implemented training requirements before the start of the study period in 2011. We estimated difference-in-differences models that compared trends in antipsychotic medication use before and after implementation of training requirements in states that have newly implemented requirements to trends in states without requirements. We also investigated whether the impact of training was larger in states with more stringent training requirements (eg, specifying a minimum number of training hours) and in NHs with a special care unit for dementia and examined similar analyses for restraint use and falls. Results: We found that training requirements were associated with a 0.59-percentage point reduction (95% CI -0.91 to -0.27) in antipsychotics use. Effects were larger in NHs with a special care unit for dementia and in states that had stricter training requirements. We also found that training requirements were associated with a 0.17-percentage point reduction (95% CI -0.26 to -0.07) in restraint use measure and had no impact on falls. Conclusions and Implications: State requirements for NH staff dementia training were associated with a small, but significant, reduction in the use of antipsychotic medication and physical restraints. (c) 2023 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
引用
收藏
页码:209 / 214.e1
页数:7
相关论文
共 50 条
  • [41] Clinical and Economic Outcomes of Interventions to Reduce Antipsychotic and Benzodiazepine Use Within Nursing Homes: A Systematic Review
    Hoyle, Daniel J.
    Bindoff, Ivan K.
    Clinnick, Lisa M.
    Peterson, Gregory M.
    Westbury, Juanita L.
    DRUGS & AGING, 2018, 35 (02) : 123 - 134
  • [42] The health professional experience of using antipsychotic medication for dementia in care homes: A study using grounded theory and focussing on inappropriate prescribing
    Almutairi, Saleh
    Masters, Kate
    Donyai, Parastou
    JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING, 2018, 25 (5-6) : 307 - 318
  • [43] Analgesic use among nursing homes residents, with and without dementia, in Poland
    Neumann-Podczaska, Agnieszka
    Nowak, Tomasz
    Suwalska, Aleksandra
    Lojko, Dorota
    Krzyminska-Siemaszko, Roma
    Kozak-Szkopek, Elzbieta
    Wieczorowska-Tobis, Katarzyna
    CLINICAL INTERVENTIONS IN AGING, 2016, 11 : 335 - 340
  • [44] High Prevalence of Antipsychotic Medication Use in Dementia Patients in German Neuropsychiatric Practices
    Bohlken, Jens
    Booker, Anke
    Kostev, Karel
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2017, 85 (06) : 345 - 351
  • [45] Impact of FDA Black Box Advisory on Antipsychotic Medication Use
    Dorsey, E. Ray
    Rabbani, Atonu
    Gallagher, Sarah A.
    Conti, Rena M.
    Alexander, G. Caleb
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (01) : 96 - 103
  • [46] A Review Exploring the Relationship Between Nursing Home Staffing and Antipsychotic Medication Use
    Mattingly T.J., II
    Neurology and Therapy, 2015, 4 (2) : 169 - 175
  • [47] Pragmatic trials may help to identify effective strategies to reduce nursing home antipsychotic medication use
    Baier, Rosa R.
    Mor, Vincent
    ISRAEL JOURNAL OF HEALTH POLICY RESEARCH, 2017, 6
  • [48] Cross-national comparison of medication use in Australian and Dutch nursing homes
    Taxis, Katja
    Kochen, Sjoerd
    Wouters, Hans
    Boersma, Froukje
    Gerard, Maring Jan
    Mulder, Hans
    Pavlovic, Jugoslav
    Stevens, Gerard
    McLachlan, Andrew
    Pont, Lisa G.
    AGE AND AGEING, 2017, 46 (02) : 320 - 323
  • [49] Medication use in nursing homes in Iceland 2002-2004. A descriptive study
    Hansdottir, Helga
    Gudmannsson, Petur G.
    LAEKNABLADID, 2013, 99 (09): : 383 - 389
  • [50] Effect of Academic Detailing on Promoting Appropriate Prescribing of Antipsychotic Medication in Nursing Homes A Cluster Randomized Clinical Trial
    Tadrous, Mina
    Fung, Kinwah
    Desveaux, Laura
    Gomes, Tara
    Taljaard, Monica
    Grimshaw, Jeremy M.
    Bell, Chaim M.
    Ivers, Noah M.
    JAMA NETWORK OPEN, 2020, 3 (05) : E205724